Identification and characterization of a novel repressor of beta-interferon gene expression - PubMed (original) (raw)
Identification and characterization of a novel repressor of beta-interferon gene expression
A D Keller et al. Genes Dev. 1991 May.
Free article
Abstract
We have identified and characterized a novel repressor of human beta-interferon (beta-IFN) gene expression. This protein, designated PRDI-BF1, binds specifically to the PRDI element of the beta-IFN gene promoter and is distinct from previously reported proteins that bind to this sequence. PRDI-BF1 is an 88-kD protein containing five zinc-finger motifs. Cotransfection experiments in cultured mammalian cells revealed that PRDI-BF1 is a potent repressor of PRDI-dependent transcription. PRDI-BF1 blocks virus induction of the intact beta-IFN gene promoter and of synthetic promoters containing multiple PRDI sites. PRDI-BF1 can also block the SV40 enhancer when PRDI sites are located between the enhancer and the promoter. This repression is highly dependent on the location of the PRDI sites, however, indicating that PRDI-BF1 cannot act at a distance. On the basis of the properties of PRDI-BF1 and the observation that PRDI-BF1 mRNA accumulation is virus inducible, we propose that PRDI-BF1 may act as a postinduction repressor of the beta-IFN gene by displacing positive regulatory proteins from the PRDI site of the promoter.
Similar articles
- PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins.
Ren B, Chee KJ, Kim TH, Maniatis T. Ren B, et al. Genes Dev. 1999 Jan 1;13(1):125-37. doi: 10.1101/gad.13.1.125. Genes Dev. 1999. PMID: 9887105 Free PMC article. - Only two of the five zinc fingers of the eukaryotic transcriptional repressor PRDI-BF1 are required for sequence-specific DNA binding.
Keller AD, Maniatis T. Keller AD, et al. Mol Cell Biol. 1992 May;12(5):1940-9. doi: 10.1128/mcb.12.5.1940-1949.1992. Mol Cell Biol. 1992. PMID: 1569931 Free PMC article. - Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
Chen H, Gilbert CA, Hudson JA, Bolick SC, Wright KL, Piskurich JF. Chen H, et al. Mol Immunol. 2007 Feb;44(6):1461-70. doi: 10.1016/j.molimm.2006.04.026. Epub 2006 Jun 12. Mol Immunol. 2007. PMID: 16765445 Free PMC article. - Type I interferon gene expression: differential expression of IFN-A genes induced by viruses and double-stranded RNA.
Bragança J, Civas A. Bragança J, et al. Biochimie. 1998 Aug-Sep;80(8-9):673-87. doi: 10.1016/s0300-9084(99)80021-2. Biochimie. 1998. PMID: 9865490 Review. - Transcriptional repression of type I IFN genes.
Lopez S, Navarro S. Lopez S, et al. Biochimie. 1998 Aug-Sep;80(8-9):689-701. doi: 10.1016/s0300-9084(99)80022-4. Biochimie. 1998. PMID: 9865491 Review.
Cited by
- Same rule, different genes: Blimp1 is a pair-rule gene in the milkweed bug Oncopeltus fasciatus.
Reding K, Chung M, Heath A, Hotopp JD, Pick L. Reding K, et al. Sci Adv. 2024 Nov 15;10(46):eadq9045. doi: 10.1126/sciadv.adq9045. Epub 2024 Nov 15. Sci Adv. 2024. PMID: 39546609 Free PMC article. - Adaptive Evolution and Functional Differentiation of Testis-Expressed Genes in Theria.
Katsura Y, Shigenobu S, Satta Y. Katsura Y, et al. Animals (Basel). 2024 Aug 9;14(16):2316. doi: 10.3390/ani14162316. Animals (Basel). 2024. PMID: 39199849 Free PMC article. - Prdm1 positively regulates liver Group 1 ILCs cancer immune surveillance and preserves functional heterogeneity.
He J, Gao L, Wang P, Chan WK, Zheng Y, Zhang Y, Sun J, Li X, Wang J, Li XH, Chen H, Yang Z, Wang Y. He J, et al. Elife. 2024 Aug 12;13:RP92948. doi: 10.7554/eLife.92948. Elife. 2024. PMID: 39133873 Free PMC article. - PHLDA1-PRDM1 mediates the effect of lentiviral vectors on fate-determination of human retinal progenitor cells.
Hu X, Chen J, Dai W, Xiao Y, Chen X, Chen Z, Zhang S, Hu Y. Hu X, et al. Cell Mol Life Sci. 2024 Jul 16;81(1):305. doi: 10.1007/s00018-024-05279-z. Cell Mol Life Sci. 2024. PMID: 39012348 Free PMC article. - Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies.
Xiang M, Li H, Zhan Y, Ma D, Gao Q, Fang Y. Xiang M, et al. Mol Cancer. 2024 Apr 5;23(1):73. doi: 10.1186/s12943-024-01987-z. Mol Cancer. 2024. PMID: 38581063 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases